Page last updated: 2024-11-02

phenoxybenzamine and Lupus Erythematosus, Systemic

phenoxybenzamine has been researched along with Lupus Erythematosus, Systemic in 2 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research Excerpts

ExcerptRelevanceReference
"Mixed connective tissue disease is characterized by overlapping features of classic connective tissue diseases and the presence of antibodies to ribonucleoprotein."2.36Mixed connective tissue disease: an overview. ( Callen, JP, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blunt, RJ1
Porter, JM1
Callen, JP1

Reviews

2 reviews available for phenoxybenzamine and Lupus Erythematosus, Systemic

ArticleYear
Raynaud syndrome.
    Seminars in arthritis and rheumatism, 1981, Volume: 10, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Angiography; Antibodies, Antinuclear; Arterial Occlusive Disease

1981
Mixed connective tissue disease: an overview.
    Southern medical journal, 1982, Volume: 75, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Child; Cold Temperature; D

1982